Skin & Cosmetic Research Peptides Guide

This guide covers 3 research peptides in the Skin & Cosmetic category. Each compound is evaluated on its evidence base, mechanism, safety profile, and current clinical status.

GHK, or Gly-His-Lys, is a naturally occurring tripeptide found in human plasma, saliva, and urine, with levels that diminish as individuals age. Its extensive research history has primarily focused on its roles in wound healing, tissue repair, and the modulation of gene expression related to collagen synthesis and tissue remodeling. The copper-bound form, GHK-Cu, has garnered significant attention in the cosmetic industry due to its purported benefits in promoting skin health and reducing signs of aging. Studies indicate that GHK can stimulate the production of glycosaminoglycans and collagen, which are vital for maintaining skin elasticity and hydration. However, while GHK is recognized as a cosmetic ingredient, it remains classified as a research compound, necessitating further clinical investigation to fully establish its efficacy and safety in various applications.

Pal-AHK, or Palmitoyl Tripeptide-3, is a lipopeptide that combines a palmitoyl group with the AHK copper-binding tripeptide sequence. This structural modification enhances its ability to penetrate the skin and scalp, making it a candidate for topical applications focused on hair follicle stimulation and overall scalp health. Research surrounding Pal-AHK suggests its potential in promoting hair growth, although clinical data remains limited. Most studies have been conducted in vitro, indicating that while the peptide shows promise, further research is needed to substantiate its claims in real-world applications. As a cosmetic ingredient, Pal-AHK is primarily marketed for hair growth formulations and scalp treatments, but its efficacy in these areas requires more robust clinical validation.

Palmitoyl Dipeptide-6 is a lipopeptide that has emerged as a promising alternative to traditional retinoids in cosmetic formulations. Its mechanism of action involves the activation of retinoid-like signaling pathways in keratinocytes and fibroblasts, stimulating skin renewal processes while minimizing the irritation commonly associated with retinoid use. Preliminary in vitro studies and small clinical trials suggest that Palmitoyl Dipeptide-6 may enhance skin texture and reduce the appearance of fine lines, making it an appealing option for sensitive skin formulations. Despite its potential, the evidence base remains classified as limited, with a need for further investigation to fully understand its long-term effects and safety profile as a cosmetic ingredient.